MEERA DHARAMDASANI: Open Payments
NPI 1548962004 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $154 |
| Janssen Biotech, Inc. | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: SKYRIZI, TREMFYA, REZDIFFRA, ENTYVIO, ZENPEP, DUPIXENT, CREON.
Industry payments across FL — which companies pay providers there.
